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             Introduction 
 For decades gene or protein replacement therapy has been proposed as 
means of preventing and treating various human diseases, in particular cancer [1] 
and monogenic diseases such as hemophilia and cystic disease, fibrosis [2–5]. The 
delivery of proteins or nucleic acids to the target cells is carried out through various 
mechanisms; these include viral vectors, electroporation, microinjection, 
lipofection, and others [6,7]. In the past, most researchers have focused on the use 
of viral vectors that have high delivery efficiency for gene therapy [6]. However, 
some drawbacks have been noted for viral transduction methods, including: 
primarily safety of use [8,9], high cost, short-lived bioactivity, size limitation for 
DNA payload, and problems with immunogenicity and cytotoxicity [6,10,11]. As a 
result, alternative methods of creating vectors for targeted drug and DNA delivery 
are being explored. In the mid-1990s, the benefits of using bacterial carriers as 
vectors for delivery of eukaryotic plasmids were introduced with different bacteria 
being investigated such as Shigella, S. typhimurium, Salmonellatyphi, S. flexneri, L. 
Monocytogenes, E. coli and others [12–17]. E. coli is an integral part of the human 
gastrointestinal flora and is therefore considered as an alternative for delivery 
through the gut when using gene therapy. The ability of any bacteria, including E. 
coli, to act as vectors for delivery includes the uptake of target cells and the release 
of therapeutic load from vacuoles to cytosol. Professional phagocytic cells, such as 
neutrophils, dendritic cells and macrophages, absorb bacterial vectors through 
phagocytosis. Non-professional phagocytes (such as epithelial cells), which are 
often involved in disease processes, may be promising for some therapies and 
designed to actively interact with these cells [5]. 
 Unlike S. typhimurium and other bacteria that colonize tumors with necrosis, 
E. Coli Nissle 1917 (EcN) has a higher ability to target the tumor, as it mainly 
propagates in the area between necrotic and hypoxic regions of tumors [18–20], 
which guarantees the penetration into the hypoxic areas of the drug, which is loaded 
into EcN. An additional advantage of EcN is that the cell membrane of EcN can 
directly interact with the adaptive immune system and therefore reduces 
inflammation [21,22]. Moreover, serum sensitive lipopolysaccharide (LPS) of the 
EcN membrane provides rapid removal of this strain from normal organs and tissues. 
Therefore, EcN-like cells with a specific immune regulatory system and capable of 
targeting hypoxic sites have potential applications for transporting chemotherapeutic 
agents to the depth of the tumor site [23]. 
 The newest direction in the construction of bacterial vectors is, first, 
artificial magnetic labeling of bacteria, and, second, the use of microorganisms with 
natural magnetically controlled properties in order to combine targeting under the 
influence of a chemoattractant gradient and an external magnetic field gradient [24]. 
Thus, an additional advantage of using magnetically driven bacteria for drug 
delivery is that the application of a magnetic field can be used to reach a specific 
target tissue in the body without affecting other non-target tissues. An example of 
studies in the first direction is the manufacture of stochastic "microcarriers" that 
move at an average speed of up to 22.5 μm/s by attaching drug-loaded microparticles 
to embedded magnetic nanoparticles [25]. These "microcarriers" exhibit directional 
motion under the gradient of the chemoattractant and the magnetic field, 
respectively. Thus, bacterial-controlled multifunctional magnetic biosensors can be 
used for targeted delivery of drugs with significantly enhanced efficacy compared 
to passive microparticles or bacterial vectors without magnetically controlled 
properties. 
 An interesting example of a "microcarrier" in the second direction is given 
in [26]. Magnetotactic bacteria Magnetospirillum gryphiswalense (MSR-1) loaded 
with antibiotic-coupled mesoporous silica microtubes (biocomposite) were targeted 
to the infectious biofilm. A complex of MSR-1 cells with attached antibiotic 
biocomposite particles was delivered to a mature E. coli biofilm, combining the 
ability of the MSR-1 cells to move and their magnetic properties with subsequent 
antibiotic release and destruction. As a result, the potential for the use of 
magnetically driven bacterial vectors has been identified. In addition, the use of 
whole cells of magnetotactic bacteria and magnetosomes as their constituent parts is 
discusses as "reasonable therapeutic agents" for an effective delivery system targeted 
at a specific site or organ in the body [27,28]. In [28], it was shown that the magneto-
aerotactic migration behavior of magnetotactic bacteria, Magnetococcus marinus 
MC-1, can be used to transport drug-loaded nanoliposomes into hypoxic regions of 
the tumor characterized by low oxygen levels and, as a rule, resistant to anti-cancer 
therapy. Each MC-1 cell contains chains of magnetic iron-oxide nanocrystals in 
natural medium and typically move along magnetic field lines and toward low 
oxygen concentrations based on a dual system of magneto-aerotactic behavior. 
Approximately 70 drug loaded nanoliposomes were attached to each MC-1 cell c. 
Covalently bound cells of MC-1 nanoliposomes containing drugs were introduced 
near the tumor c. Magnetococcus marinus MC-1 cells were found to be alive and 
mobile and exhibited both magnetotaxis and aerotaxis responses after administration 
to mice in the peritomoral region, reaching deeper tumor areas compared to passive 
agents (microspheres and dead Magnetococcus marinus cells). Magnetic control 
resulted in up to 55% of MC-1 cells penetration into hypoxic areas in mice. These 
results suggest that it is possible to use microorganisms that exhibit magneto-
aerotactic behavior, and thus significantly improve therapeutic performance in 
hypoxic areas of tumors. Magnetococcus marinus MC-1 is a marine bacterium that 
was not expected to survive in mammals, although this has not been investigated in 
[28]. The cells of Magnetococcus marinus strain MC-1 are clinically "safe", do not 
cause adverse effects when introduced into mice according to another result of the 
paper [28]. This result is unexpected due to the common immunogenic properties of 
the gram-negative bacterial cell wall [29,30]. Therefore, it is impossible to guarantee 
the safety of this method without further detailed studies on the effects of the 
introduction of magnetotactic bacteria into living organisms. This is probably the 
reason why, as a rule, not the magnetotactic bacteria, but the magnetosomes, as their 
constituents, are used as vectors for targeted drug delivery. Thus, these structures 
cannot reproduce, cannot cause infections, and do not produce a pronounced 
immunological response, since the magnetosome membrane does not have 
lipopolysaccharides on the outer membrane of the gram-negative cell wall, which 
are known to act as endotoxins [30,31]. However, the disadvantage of using 
magnetosomes as vectors is that they are incapable of chemotaxis, and their 
manufacturing technology is high-cost. 
 
             Results and discussion 
This paper proposes a new magnetically guided bacterial vector based on EcN, 
which has all of the above benefits of using this particular E. coli strain, including 
aerotactic behavior, and which lacks the disadvantages of magnetotactic bacteria in 
terms of potential immunological response and complexity of cultivation in the 
laboratory. In this paper, it is first discovered that EcN has natural magnetically 
controlled properties, that is, EcN cells move in a gradient magnetic field of 
permanent magnets without artificial magnetic labeling. It is also shown in the paper 
that the cultivation of EcN in a medium enriched with iron chelates and under the 
influence of an external magnetic field increases several times the magnetophoretic 
mobility of EcN cells compared to cultivation under standard conditions. Thus, the 
speed of movement of EcN cells in a gradient magnetic field of laboratory magnets 
is achieved of the order of several mm/s. It has also been shown for the first time 
that the cultivation of EcN biomass is accelerated by cultivation in an external 
magnetic field, while the change in the concentration of iron chelates in the medium 
has no effect on the cultivation dynamics of the EcN culture. 
The bioinformatics analysis using comparative genomics methods in the 
BLAST program of the US National Center for Biotechnology (NCBI) was 
performed to determine whether EcN has natural magnetically driven properties, i.e. 
whether EcN is a producer of biogenic magnetic nanoparticles (BMNs). The EcN 
proteome was aligned with the amino acid sequences required for the 
biomineralization of Mam proteins of the magnetotactic bacterium 
Magnetospirillum gryphiswaldense MSR-1, for which BMN biomineralization has 
been studied in detail at the genetic level. 
The standard parameters were taken into account in the alignments to evaluate 
the homology of the amino acid sequences of the EcN proteins with the MSR-1 
proteins [32]. E-number is an indicator of the statistical significance of the 
alignment; Ident (I) is the percentage of identical amino acid residues in pairwise 
alignment of a given protein sequence; Length is length of alignment and functions 
of the proteins under study. Alignment results show that EcN is a BMN producer 
(Table. 1.). 
 
Table 1. Alignment of the proteins of the Mam-group of M. gryphiswaldense 
MSR-1 and the proteome of the bacterium EcN. 
The strain 
of the 
microorgani
sm 
Е-number (І, %) 
Proteins of Magnetospirillum gryphiswaldense MSR-1 
MamA MamB MamM MamO MamE 
Escherichia 
coli Nissle 
1917 
0.001 
(23,86) 
5e-37 
(30,54) 
2e-29 
(29,89) 
3e-09 
(29,70) 
1e-35 
(40,38) 
 Experimental confirmation of the presence of BMN in EcN cells was 
performed using atomic force microscopy (AFM) and magnetic force microscopy 
(MSM) methods (Fig. 1). 
 
       
 
Fig. 1. AFM (up) і MFM (down) images of EcN cells cultivated on standard 
medium (control). 
 The MFM image of Fig. 1 shows that an uneven distribution of magnetic 
nanoparticles in the form of clusters of different sizes is observed inside the EcN 
cells, similar to the results of [33], where a study of BMN in Escherichia coli VKM 
B-126 was performed using transmission electron microscopy. This result, 
according to the results of bioinformatics analysis of this paper (Table 1) and the 
research [34] and experimental studies of this paper (Fig. 1) and the paper [33], 
indicates that BMN available in EcN cells are amorphous. 
An aqueous solution of iron chelate (32 mg/ml) was added to intensify the 
process of BMN formation and to enhance the magnetically driven properties of EcN 
cells in standard EcN growing media such as meat-peptone agar (MFA) and meat-
peptone broth (MFB). The EcN culture was cultivated on medium supplemented 
with iron chelate for two days under optimal temperature conditions of 37°C. After 
that, the morphological characteristics of BMN bacteria have been re-evaluated by 
means of the methods of AFM and MFM (Fig. 2). 
As can be seen from Fig. 2, both the EcN cells and BMNs inside the EcN cells 
form chains after growing on a standard medium with the addition of iron chelate. 
The bacterium EcN was cultivated under four different conditions for a 
detailed study of possible methods of changing of the magnetically controlled 
properties: a) standard medium, b) standard medium with the addition of an aqueous 
solution of iron chelate (32 mg/ml), c) standard medium under the influence of an 
external magnetic field (MF) with magnetic field flux density 0.15 T, and d) standard 
medium with the addition of an aqueous solution of iron chelate (32 mg/ml) under 
the influence of an external MF with a magnetic field flux density 0.15 T. Samples 
of suspensions of the four cultures under study were analyzed at the contact surface 
of the system of two NdFeB permanent magnets (Fig. 3). 
  
  
Fig. 2. AFM (up) and MSM (down) images of EcN cells cultivated on medium 
supplemented with iron chelate. 
 
The EcN cells cultivated under the influence of an external MF manifest self-
arrangement in chain-like structures (Fig. 2). Such arrangement is typical for objects 
possessing the remnant magnetization and interacting as magnetic dipoles.  
 
 
  
 
Fig. 3. The schematic image of the system of two NdFeB permanent magnets. 
1 – cover glass; 2 – NdFeB permanent magnet with up orientation of magnetization 
as indicated by white arrows; 3 – NdFeB permanent magnet with down orientation 
of magnetization as indicated by white arrows; 4 – contact surface of two NdFeB 
permanent magnets; a=23 mm, b=30 mm, c=10 mm. 
 
To do this, 0.02 ml of each suspension with a concentration of 3 · 107 cells/ml 
was applied to the cover glass (0.2 mm thickness), the glass was placed above the 
contact surface of the system of two permanent magnets (Fig. 3). The bandwidth 
(Fig. 4) formed in the inhomogeneous MF above the contact surface of the system 
of two permanent magnets varied significantly for each of the four studied cultures, 
which characterizes the magnetic interaction of BMN of bacteria with a high-
gradient magnetic field (HGMF) created by the system of magnets. 
 
 
           
Fig. 4. The results of the study of changes in the deposition of cells of EcN in 
inhomogeneous MF above the contact surface of the system of two permanent 
magnets: a) bacteria cells cultivated on standard medium (control); b) bacteria cells 
cultivated on standard medium with the addition of chelates; c) bacteria cells 
cultivated on standard medium under the influence of external MF with magnetic 
field flux density 1500 Oe (0.15 T); d) bacteria cells cultivated on a standard medium 
with the addition of chelates under the influence of external MF with magnetic field 
flux density 1500 Oe (0.15 T). 
 
The results were analyzed (Table 2) using the Gwyddion program, which 
determined the width and surface area of the strips formed by the EcN cell clusters, 
and the average diameters of the EcN cell clusters. The numbers in brackets in Table 
2 show the increase of the respective parameters in comparison with the parameters 
for bacterial cells cultivated on standard medium (control). 
 
Table  2. The width and surface area of the strips, formed by the EcN cell 
clusters above the contact surface of the system of two permanent magnets, and the 
average diameters of the EcN cell clusters. 
 
The samples cultivated on 
The 
width of 
the 
strips, 
mm 
The surface area 
of the strips, 
mm2 
the average 
diameters of the 
EcN cell clusters, 
micron 
a) standard medium (control) 0,5 2.8 52,82 
b) standard medium with the 
addition of iron chelate 
1,2 7.4 (2,6) 66,14 (1.25) 
c) standard medium under the 
influence of external MF 
0,7 3.8 (1,4) 58,74 (1.1) 
d) standard medium with the 
addition of chelates under the 
influence of external MF 
1,75 7.8 (2,8) 65,74 (1,26) 
 
The influence of external permanent MF and the addition of iron chelates to 
the medium of growing the culture of EcN bacteria significantly affects the 
magnetophoretic mobility and magnetic susceptibility EcN cells (Table. 2). The 
mean and maximum diameters of EcN cell clusters (Fig. 5, Table 2) cultivated under 
the influence of an external constant MF are 1.24-1.26 times larger than for the 
control, and the maximum diameter of the EcN cell clusters differs slightly from the 
control for samples, cultivated with the addition of iron chelates into the medium 
(Fig. 5, Table 2). 
   
 
 
Fig. 5. The distribution of diameters of EcN cell clusters: N is a number of 
bacterial cell clusters, Nmax is a total number of bacterial cell clusters analyzed, D is 
the diameter of bacterial cell cluster; a) - cells of bacteria EcN cultivated on standard 
medium (control), b) - cells of bacteria EcN cultivated on standard medium with the 
addition of iron chelate, c) - cells of bacteria EcN cultivated on standard medium 
under the influence of external permanent MF, d) - cells of bacteria EcN cultivated 
on standard medium with the addition of iron chelate under the influence of external 
permanent MF.  
 
The magnetophoretic mobility of four EcN test specimens was compared by 
measuring the average velocity of bacteria under an inhomogeneous MF at the 
contact surface of a system of two permanent magnets (Table 3). Table 3 shows the 
increase in the average velocity of movement of EcN cells relative to the control in 
parentheses. 
The energy U  of EcN cell cluster in an external magnetic field can be 
calculated (using Gaussian) units as  
2
2
cl
H
U V

    
where   is the difference between magnetic susceptibilities of EcN cell cluster and 
magnetic susceptibility of medium (water), clV  is the volume of EcN cell cluster, H  
is an external magnetic field strength. The volume of spherical EcN cell cluster 
is 
34
3
clr , where clr  is the average radius of EcN cell cluster. The gradient magnetic 
force acting on EcN cell cluster is 
 F grad U  .  
The Stokes force acting on a spherical EcN cell cluster is  
6St clF r v  , 
where   is the dynamic viscosity of liquid medium, the sign “-” means that the 
Stokes force is antiparallel to the velocity of EcN cell cluster v . The gradient 
magnetic force and the Stokes force have the same value for the case of movement 
of EcN cell cluster with a constant velocity. Then the relation is valid: 
2 21
9
clv gradH r

  
The ratio of the values of the magnetic susceptibilities of EcN cells cultivated 
under different special conditions to the magnetic susceptibility of the cells EcN of 
the control sample was calculated based on the values of the average velocities of 
cell movement under gradient magnetic field and taking on account the previous 
equations: 
 
 
2
(1) (2)(1)
2(2) (2) (1)
cl
cl
v r
v r



, 
where the indexes 
(1)
and 
(2)
 correspond to EcN cells, cultivated under special 
conditions and standard conditions (control) respectively; 
 If EcN synthetize single domain BMNs then their magnetization is equal to 
magnetization saturation of the BMN material 0M  and it is oriented parallel to the 
external magnetic field H . Than the energy of EcN cell cluster in an external 
magnetic field can be calculated (using Gaussian) units as 
0 BMNsU M H V   , 
where BMNsV  is the volume BMN material inside EcN cell cluster. The following 
relation is valid taking on account that the gradient magnetic force is equal the Stokes 
force 
 
 
(1) (1)(1)
(2) (2) (2)
clBMNs
BMNs cl
v rV
V v r

. 
Generalization of the results of the calculation of the average velocities of 
bacterial cells cultivated under different conditions and the ratios of their magnetic 
susceptibilities are given in Table. 3. 
 
 
 
 
Table 3. The results of the calculations of the average velocity of movement of cells 
EcN under the inhomogeneous MF of the system of two permanent magnets and the 
ratio of their magnetic susceptibilities. 
Cultivation conditions The average 
velocity of 
movement of 
cells, mm/s 
Magnetic susceptibility 
divided by the magnetic 
susceptibility of the control 
a) on a standard medium (control) 0,7 1 
b) on a standard medium with the 
addition of iron chelate 
1,6 (2.3) 1,65 
c) in a standard medium under the 
influence of an external MF 
1 (1.4) 1,11 
d) on a standard medium with the 
addition of chelates under the 
influence of an external MF 
1,9 (2.7) 1,82 
 
          Table 3 shows that the effect of iron chelate concentration in the medium on 
the average velocity of cell movement under the inhomogeneous MF exceeds the 
effect of the external MF on this parameter. 
Studies of the influence of the medium with the addition of iron chelate and 
the external MF on the intensity of cultivation of EcN as a bacterium producing 
BMN showed that the cultivation of bacteria under the influence of external MF with 
the 1500 Oe (0.15 T) magnetic field flux density is 14% greater than under control. 
However, the addition of iron chelate did not have any significant effect on 
cultivation processes (Fig. 6). 
 
 Fig. 6. Growth curves of E. coli Nissle 1917 cultivated under different 
conditions: N is the number of cell clusters per ml of cell suspension, t is the time of 
cultivation; 1 - cultures cultivated on medium with the addition of iron chelate under 
the influence of external MF; 2 - cultures cultivated on a standard environment under 
the influence of an external MF; 3 - cultures cultivated on the medium with the 
addition of iron chelates; 4 - cultures cultivated on standard environment (control) 
 
Application of an external magnetic field resulted in increase of rate of growth 
of E. coli Nissle 1917. Thus, the study proved the effectiveness of using such 
conditions of cultivation as the application of an external magnetic field and adding 
to the nutrient medium of iron chelate to enhance the magnetic susceptibility and 
magnetophoretic mobility of bacteria producing BMN. As a result, the ways are 
revealed to create an effective vector for targeting drug delivery of anticancer drugs 
and therapeutic genes based on the bacterial strain E. coli Nissle 1917. The increase 
of the rate of growth of E. coli Nissle 1917 under an external magnetic field can be 
explained based on the idea about metabolic functions of BMNs that BMNs 
represent a nano-device for magnetic capture of cluster-type components [35,36]. 
The rate of growth increases because the size of the zone of capture of cluster-type 
components increases due to application of a magnetic field [35–37] during 
cultivation of E. coli Nissle 1917. 
Nano- or microcontainers are used to immobilize drug molecules on the 
surface of bacterial cells. Liposomes are most appropriate for this purpose. 
Liposomes represent microscopically spherical vesicles, usually smaller than 1.5 
microns in size, consisting of one or more lipid layers [38]. Unlike other types of 
nano- and microcontainers (fullerenes, micelles, carbon nanotubes, etc.), liposomes 
are synthesized from natural phospholipids and are similar in chemical composition 
to cell membranes and therefore do not require additional modification to acquire 
biocompatibility, do not cause allergic reactions and are biodegradable. In addition, 
liposomes are virtually versatile microcontainers because they can carry a wide 
range of different classes of medical chemotherapy agents. The release of drug in 
such a targeted delivery system is due to the release of lipase enzymes by cells and 
liposome-destroying oxidizing agents [39]. Such a mechanism is capable of 
providing a gradual release of the drug, thereby prolonging its action. 
Egg lecithin was used for the synthesis of liposomes. Egg lecithin was isolated 
as follows. 6 ml of ethyl alcohol was added to 1 g of dry egg yolk. Then the liquid 
was filtered off and 0.4 ml of acetone was added. The opacification of the solution 
indicated the deposition of lecithin. The mixture was centrifuged for 3-4 min at 2000 
rpm. The supernatant was drained and the precipitated lecithin was dissolved in 10 
ml of ethanol and used for liposome synthesis. 
Liposomes were obtained by the method of dehydration/rehydration 
according to the following method: the obtained 1% solution of lecithin in ethyl 
alcohol was introduced into a round bottom flask of 100 cm3 rotary evaporator and 
evaporated at a water bath temperature of 60°C to form a lipid film on the walls of 
the flask. The mass of phospholipids obtained was equal to 2.42 g. Next, 15 ml of 
centimolar (0.01M) sodium phosphate buffer solution (pH = 7.2-7.4) was added to 
the flask and shaken for 2 min to form liposomes. The results of liposome formation 
were verified by light microscopy (Fig. 7). 
 
 
Fig. 7. Micrograph of liposomes. 
 
The size of the liposomes was measured by microwave analysis in Gwyddion. 
The average value of liposome diameters was equal to about 1 micron. 
The surface modification of liposomes was performed with dialdehyde 
dextran to immobilize liposomes on bacterial cells. The choice of this method to 
create a targeted delivery system is justified, firstly, by the simplicity of its 
implementation, and, secondly, by the fact that dialdehydextran is subject to 
complete biodegradation in the human body unlike other polymers used for liposome 
surface modification. 
The synthesis of dialdehyde dextran by dextran peroxidation was carried out 
according to the following procedure. 3 ml of 30% hydrogen peroxide solution was 
added to 15 ml of 5% aqueous dextran solution (40 kDa). The resulting mixture was 
stirred and poured into a flat bottomed vessel (Petri dishes) so that the thickness of 
the fluid layer did not exceed 3 mm. The oxidation was carried out in a heat oven at 
90°C for 2 hours. 
The resulting dry powder of dialdehyde dextran weighing 1.6 g was dissolved 
in 25 ml of distilled water. 20 ml of this solution was added to 15 ml of the liposomal 
suspension and stirred with a laboratory stirrer for 1 h at room temperature to form 
the polymer shell on the liposome surface. Thereafter, another 5 ml of 
dialdehydextran solution and 12 ml of bacterial suspension at a concentration of 3 · 
107 cells/ml were added to the mixture and stirred with a stirrer for 20 min, resulting 
in the binding of liposomes to bacterial cells. 
The formation of liposomal-bacterial complexes was evaluated by light 
microscopy, the suspension samples were fixed on a slide and stained with fuchsin. 
In this case, the bacterial cells became dark in color, and the liposomes had a lighter 
pink color. Micrographs (Fig. 9) show that liposomes bind to bacterial cells, forming 
complexes. 
 
 
Fig. 9. Micrograph of bacterial-liposomal complexes. 
 
Thus, a targeted drug delivery system was obtained based on the probiotic 
strain of E. coli Nissle 1917 and lecithin liposomes, which can be effectively 
delivered to the tumor due to magnetophoresis of E. coli Nissle 1917 using external 
control of these complexes by magnetic field. 
 
 Conclusions 
For the first time, it was experimentally discovered that the bacterium 
Escherichia coli Nissle 1917, which is a known vector for drug delivery and gene 
therapy, has natural magnetically controlled properties (or by other words it is 
magnetically sensitive), that is, it has sufficient magnetic susceptibility to manifest 
controlled movement under gradient magnetic field of permanent magnets. Analysis 
by comparative genomics methods and atomic force and magnetic force microscopy 
have shown that the natural magnetically controlled properties of Escherichia coli 
Nissle 1917 are based on the fact that it is a BMN producer. 
 The methods of increase of magnetophoretic mobility and magnetic 
susceptibility of Escherichia coli Nissle 1917 were first discovered in the paper. The 
quantity of BMNs and magnetic susceptibility of E. coli Nissle 1917 cells increase 
2-3 times due to cultivation on a nutrient medium with the addition of iron chelate 
and under the influence of an external magnetic field with a magnetic field flux 
density of 1500 Oe (0.15 T). 
It was also found that the growth rate of E. coli Nissle 1917 cells increased by 
14% under the influence of an external constant magnetic field of 1500 Oe (0.15 T) 
and did not change when chelates were added to the culture medium compared to 
the control. 
The results of the paper are important for using E. coli Nissle 1917 cell culture 
for targeted drug and gene delivery using magnetic technology. 
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